摘要
普通感冒是临床上十分常见的疾病,应用中医药治疗具有一定的特点和优势。近些年来,申报这类中药新药的临床研究依然是热点,经对现有在我国已上市并列入法定标准的治疗普通感冒的中成药进行了梳理及分析,同类药物存在较多的趋势,如何研发更加有效安全的这类新药,避免重复申报,值得业内同道思考。
Common cold is a common clinical disease. The application of Chinese medicine has certain characteristics and advantages. It is still hot to apply clinical research of such new Chinese medicines. Here,we reviewed and analyzed traditional Chinese medicine of mandatory standard and found some trends. How to develop new drugs that are more effective and safe,and avoid duplicate applications,are worth considering in the industry.
作者
安娜
吕佳康
陈佳丽
吴艳
AN Na, LU Jia- kang, CHEN Jia -li, wu Yan(Center for Drug Evaluation, China Food and Drug Administration, Bering 100022, Chin)
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2018年第14期1732-1734,共3页
The Chinese Journal of Clinical Pharmacology
关键词
中药新药
普通感冒
研发
申报
临床研究
traditional Chinese medicine new drugs
common cold
research
development
clinical study